MDS' Q2 Revenues Drop 21 Percent

MDS also swung to a loss in the quarter. Its mass spec sales sagged amid "soft end-user demand," the firm said.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.